title: Are we closer to selective immunotherapy for autoimmune diseases?
abstract: The discipline of immunotherapy has promised much in the restricted confines of the laboratory but, so far, has delivered little in the harsh reality of the clinic. At a recent conference to celebrate the opening of Roche Milano Ricerche*, the hopes, successes and failures in this complex field were presented for examination.
authors.affiliation: Roche Research Centre, Welwyn Garden City, Herts, UK.
authors.forename: A
authors.initials: A
authors.lastname: Lamont
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008285:Major Histocompatibility Complex / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology